Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus.
Urinary excretion of cyclic adenosine monophosphate (cAMP) is assessed in response to pitressin stimulation in three patients with nephrogenic diabetes insipidus, four carriers and seven controls. There is no significant difference in cAMP excretion between these groups when corrected for surface area, nor is there any significant increase in excretion after pitressin stimulation. There is very close correlation between urinary cAMP and both urinary concentration and urinary creatinine excretion. Urinary cAMP after pitressin stimulation does not discriminate between carriers of nephrogenic diabetes insipidus and control subjects.
D000328:Adult; D002648:Child; D002675:Child, Preschool; D003404:Creatinine / Q000652:urine; D000242:Cyclic AMP / Q000652:urine*; D003919:Diabetes Insipidus / Q000151:congenital / Q000235:genetics* / Q000652:urine; D005260:Female; D006580:Genetic Carrier Screening; D006801:Humans; D007674:Kidney Diseases / Q000151:congenital / Q000235:genetics* / Q000652:urine; D008297:Male; D014667:Vasopressins
D014667:Vasopressins; D003404:Creatinine; D000242:Cyclic AMP